Ramsey Cheung
Appearances
- DateMay 6, 2023BACKGROUND: Hepatic encephalopathy (HE) is associated with increased mortality, falls, and frequent hospitalizations. Patient reported outcomes (PROs) are useful tools to assess health-related quality of life (HRQOL) measures such as impairment of sleep, cognition, or activity…
Presenter
Stanford University Hospital - DateMay 7, 2023Chronic hepatitis delta (CHD) typically leads to cirrhosis and hepatic decompensation. The only treatment option for CHD patients with decompensated cirrhosis is liver transplantation with associated short- and long-term complications…
Presenter
Speakers
- DateMay 8, 2023Transplantation of hepatitis C (HCV) positive lungs has been shown to be a safe means of combating organ shortages in the era of direct-acting antivirals against HCV…
Presenters
Speakers
Mayo Foundation for Medical Education and Research - DateMay 20, 2024INTRODUCTION: Low adenoma detection rate (ADR) is a predictor of fatal post-colonoscopy colorectal cancer. Water exchange (WE) colonoscopy significantly increased ADR compared with conventional gas (air, CO2) insufflation in several RTC…
Presenter
Speakers
- DateMay 18, 2024BACKGROUND: Adults with metabolic dysfunction associated steatotic liver disease (MASLD) have high risk of cardiovascular disease (CVD) and CVD-related mortality. However, it remains unclear whether adults with lean vs…
Presenter
Stanford University Hospital - DateMay 18, 2024BACKGROUND: The rising clinical burden of alcohol related liver disease in the U.S. has been exacerbated by COVID-19 pandemic-related increases in high-risk alcohol use…
Presenter